176 related articles for article (PubMed ID: 38102228)
1. Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation.
Viergever BJ; Raats DAE; Geurts V; Mullenders J; Jonges TN; van der Heijden MS; van Es JH; Kranenburg O; Meijer RP
Br J Cancer; 2024 Feb; 130(3):369-379. PubMed ID: 38102228
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
[TBL] [Abstract][Full Text] [Related]
3. Urothelial cancer organoids: a tool for bladder cancer research.
Meijer RP
Pathologe; 2021 Dec; 42(Suppl 2):165-169. PubMed ID: 34623463
[TBL] [Abstract][Full Text] [Related]
4. Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery.
Kim YS; Hsieh AC; Lam HM
Eur Urol Focus; 2022 May; 8(3):657-659. PubMed ID: 35915037
[TBL] [Abstract][Full Text] [Related]
5. Mouse and human urothelial cancer organoids: A tool for bladder cancer research.
Mullenders J; de Jongh E; Brousali A; Roosen M; Blom JPA; Begthel H; Korving J; Jonges T; Kranenburg O; Meijer R; Clevers HC
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4567-4574. PubMed ID: 30787188
[TBL] [Abstract][Full Text] [Related]
6. Current and innovative approaches in the treatment of non-muscle invasive bladder cancer: the role of transurethral resection of bladder tumor and organoids.
Taskovska M; Kreft ME; Smrkolj T
Radiol Oncol; 2020 May; 54(2):135-143. PubMed ID: 32374292
[TBL] [Abstract][Full Text] [Related]
7. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
8. A Protocol for Organoids from the Urine of Bladder Cancer Patients.
Walz S; Pollehne P; Geng R; Schneider J; Maas M; Aicher WK; Stenzl A; Amend B; Harland N
Cells; 2023 Aug; 12(17):. PubMed ID: 37681920
[TBL] [Abstract][Full Text] [Related]
9. Bladder cancer organoids as a functional system to model different disease stages and therapy response.
Minoli M; Cantore T; Hanhart D; Kiener M; Fedrizzi T; La Manna F; Karkampouna S; Chouvardas P; Genitsch V; Rodriguez-Calero A; Compérat E; Klima I; Gasperini P; Kiss B; Seiler R; Demichelis F; Thalmann GN; Kruithof-de Julio M
Nat Commun; 2023 Apr; 14(1):2214. PubMed ID: 37072390
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method.
Elbadawy M; Fujisaka K; Yamamoto H; Tsunedomi R; Nagano H; Ayame H; Ishihara Y; Mori T; Azakami D; Uchide T; Fukushima R; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Omatsu T; Mizutani T; Usui T; Sasaki K
Biomed Pharmacother; 2022 Jul; 151():113105. PubMed ID: 35605292
[TBL] [Abstract][Full Text] [Related]
11. Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.
Lee SH; Hu W; Matulay JT; Silva MV; Owczarek TB; Kim K; Chua CW; Barlow LJ; Kandoth C; Williams AB; Bergren SK; Pietzak EJ; Anderson CB; Benson MC; Coleman JA; Taylor BS; Abate-Shen C; McKiernan JM; Al-Ahmadie H; Solit DB; Shen MM
Cell; 2018 Apr; 173(2):515-528.e17. PubMed ID: 29625057
[TBL] [Abstract][Full Text] [Related]
12. Culture of Bladder Cancer Organoids as Precision Medicine Tools.
Thomas PB; Perera MPJ; Alinezhad S; Joshi A; Saadat P; Nicholls C; Devonport CP; Calabrese AR; Templeton AR; Wood JR; Mackenzie NJ; Jeffery PL; Vela I; Williams ED
J Vis Exp; 2021 Dec; (178):. PubMed ID: 35037658
[TBL] [Abstract][Full Text] [Related]
13. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers.
Shiihara M; Ishikawa T; Saiki Y; Omori Y; Hirose K; Fukushige S; Ikari N; Higuchi R; Yamamoto M; Morikawa T; Nakagawa K; Hayashi H; Mizuma M; Ohtsuka H; Motoi F; Unno M; Okamura Y; Kinoshita K; Furukawa T
Eur J Cancer; 2021 May; 148():239-250. PubMed ID: 33752134
[TBL] [Abstract][Full Text] [Related]
14. Preclinical models for bladder cancer therapy research.
Ertl I; Shariat SF; Berger W; Englinger B
Curr Opin Urol; 2024 Jul; 34(4):244-250. PubMed ID: 38630912
[TBL] [Abstract][Full Text] [Related]
15. Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
Birkenkamp-Demtröder K; Nordentoft I; Christensen E; Høyer S; Reinert T; Vang S; Borre M; Agerbæk M; Jensen JB; Ørntoft TF; Dyrskjøt L
Eur Urol; 2016 Jul; 70(1):75-82. PubMed ID: 26803478
[TBL] [Abstract][Full Text] [Related]
16. SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis.
Tan P; Wang M; Zhong A; Wang Y; Du J; Wang J; Qi L; Bi Z; Zhang P; Lin T; Zhang J; Yang L; Chen J; Han P; Gong Q; Liu Y; Chen C; Wei Q
Oncogene; 2021 Oct; 40(42):6081-6092. PubMed ID: 34471236
[TBL] [Abstract][Full Text] [Related]
17. Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids.
Becker L; Fischer F; Fleck JL; Harland N; Herkommer A; Stenzl A; Aicher WK; Schenke-Layland K; Marzi J
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805961
[TBL] [Abstract][Full Text] [Related]
18. Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy.
Bacon JVW; Müller DC; Ritch E; Annala M; Dugas SG; Herberts C; Vandekerkhove G; Seifert H; Zellweger T; Black PC; Bubendorf L; Wyatt AW; Rentsch CA
Eur Urol Oncol; 2022 Dec; 5(6):677-686. PubMed ID: 34895867
[TBL] [Abstract][Full Text] [Related]
19. [Organoids as a milestone on the way to personalized treatment of urothelial carcinoma: a systematic review].
Melzer MK; Zehe V; Zengerling F; Wezel F; Günes C; Maisch P; Bolenz C
Urologie; 2022 Jul; 61(7):745-752. PubMed ID: 35925247
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer.
Tölle A; Jung M; Rabenhorst S; Kilic E; Jung K; Weikert S
Oncol Rep; 2013 Oct; 30(4):1949-56. PubMed ID: 23877086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
